Clover Health Stock Climbs on HHS Star Re-Rating

Dow Jones
Jun 11

By Dean Seal

 

Shares of Clover Health Investments jumped after regulators raised their rating of the company's primary healthcare plan.

The stock was up 19% at $5.12 on Wednesday. Shares have doubled since the start of the year.

The healthcare and technology company said before the opening bell that after it won a legal challenge last month on the Centers for Medicare & Medicaid Services' previous 3.5 star rating, the agency has recalculated and provided it a 4.5 star rating.

The star rating indicates the government's assessment of the quality and clinical outcomes of a provider's PPO Medicare Advantage plan. Clover's PPO plan covers over 97% of its members.

 

Write to Dean Seal at dean.seal@wsj.com

 

(END) Dow Jones Newswires

June 10, 2026 12:14 ET (16:14 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10